SS Innovations International, Inc. announced that Sarah Romano ceased serving as its Chief Financial Officer effective August 21, 2026. The filing states that her departure was not the result of any disagreement with the Company regarding financial reporting, internal controls, operations, policies, or accounting practices. SS Innovations International operates in the information technology services industry.

SS Innovations International reported unaudited financial results for the second quarter ended June 30, 2026. Revenue increased 39.4% to $13.9 million from $10.0 million in the prior year period, driven by a 30.4% rise in SSi Mantra surgical robotic system installations to 30 units. Gross margin decreased to 50.9% from 59.1%, resulting in a net loss of $2.7 million, or $(0.01) per diluted share, compared to a $0.3 million loss previously. Cash and cash equivalents totaled $13.6 million as of June 30, with no long-term debt. The company also announced the successful completion of a robotic telesurgery between Colombia and India in July 2026, spanning over 13,600 miles. SS Innovations International develops innovative surgical robotic technologies to make robotic surgery affordable and accessible globally.

SS Innovations International, Inc. announced that its SSi Mantra surgical robotic system will be showcased at the 2026 Society of Robotic Surgery Annual Meeting in Hollywood, Florida, from July 23 to 26, 2026. The event will feature a live-broadcast kidney telesurgery, a partial nephrectomy, performed by Dr. Amitabh Singh from India on a patient in New Delhi. CEO Dr. Sudhir Srivastava will also participate in several breakout sessions and panels. As of July 6, 2026, the SSi Mantra system has completed 12,375 multi-specialty procedures, including 653 cardiac and 178 telesurgeries. The company develops surgical robotic technologies to increase global accessibility to robotic surgery.

SS Innovations International, Inc. announced the appointment of Sarah M. Romano as the new Chief Financial Officer, effective August 3, 2026. Ms. Romano, a CPA, brings over two decades of financial experience from previous CFO roles at Vicarious Surgical Inc., Entero Therapeutics, Inc., and Kiora Pharmaceuticals, Inc. Her employment agreement includes an annual base compensation of $440,000, an annual cash bonus eligibility, and a grant of 750,000 stock options under the 2026 Incentive Stock Plan. SS Innovations International, Inc. operates in the medical technology sector, developing surgical robotics and surgical technology solutions.

SS Innovations International, Inc. announced that its subsidiary, the SS International Centre for Robotics Surgery, SSICRS, has graduated its first class of healthcare professionals in a specialized training course for robotic-assisted cardiac surgery using the SSi Mantra surgical robotic system. SS Innovations International, Inc. operates in the medical technology industry and develops advanced surgical robotic systems.